Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit

Publisher： John Wiley & Sons Inc

E-ISSN： 1743-7563|11|4|343-351

ISSN： 1743-7555

Source： ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.11, Iss.4, 2015-12, pp. : 343-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 4, 2015-08 ,pp. : 819-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population‐based study of bladder cancer

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 373-381

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-12 ,pp. : 609-615

Karger

Access to resources Recommend Favorite

Distinctive oncological features of stage IIIA colorectal cancer: Analysis of prognostic factors for selective adjuvant chemotherapy

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 7, 2015-06 ,pp. : 882-890

John Wiley & Sons Inc

Access to resources Recommend Favorite

Campto^® – Strategies for Adjuvant and Neoadjuvant Chemotherapy of Colorectal Cancer

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-05 ,pp. : 18-22

Karger

Access to resources Recommend Favorite